ORMDL2
ORM1-like protein 2
Also known as: adoplin-2, HSPC160, MST095, MSTP095, ORML2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q53FV1
- Gene
- ORMDL2
- Ensembl
- ENSG00000123353
- Chromosome
- 12
- Canonical length
- 153 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
Involved in ceramide metabolic process. Acts upstream of or within negative regulation of ceramide biosynthetic process. Located in endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
153 residues, UniProt reviewed canonical sequence.
>Q53FV1|ORMDL2
1 MNVGVAHSEV NPNTRVMNSR GIWLAYIILV GLLHMVLLSI PFFSIPVVWT LTNVIHNLAT
61 YVFLHTVKGT PFETPDQGKA RLLTHWEQMD YGLQFTSSRK FLSISPIVLY LLASFYTKYD
121 AAHFLINTAS LLSVLLPKLP QFHGVRVFGI NKYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ORMDL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 73 nTPM
Expression across tissuesHPA
Tissue
- esophagus: 73 nTPM
- choroid plexus: 56 nTPM
- epididymis: 48 nTPM
- rectum: 45 nTPM
- liver: 45 nTPM
- parathyroid gland: 42 nTPM
Single-cell type
- esophageal apical cells: 805 nCPM
- esophageal suprabasal cells: 282 nCPM
- late primary spermatocytes: 215 nCPM
- syncytiotrophoblasts: 189 nCPM
- early spermatids: 167 nCPM
- extravillous trophoblasts: 152 nCPM
Immune cell
- plasmacytoid DC: 120 nTPM
- non-classical monocyte: 109 nTPM
- T-reg: 108 nTPM
- eosinophil: 108 nTPM
- memory B-cell: 94 nTPM
- intermediate monocyte: 93 nTPM
Brain region
- choroid plexus: 33 nTPM
- white matter: 23 nTPM
- medulla oblongata: 21 nTPM
- thalamus: 20 nTPM
- hypothalamus: 20 nTPM
- cerebellum: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0.19
- gnomAD missense Z
- 0.46
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ceramide metabolic process
- intracellular sphingolipid homeostasis
- negative regulation of ceramide biosynthetic process
- sphingolipid biosynthetic process
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ORMDL2 as an antibody target. Whether an autoantibody or antibody against ORMDL2 could matter depends on whether native ORMDL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ORMDL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ORMDL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...